BAJAJ HEALTHCARE LIMITED

Company Introduction:

BAJAJ HEALTHCARE LIMITED is an Indian pharmaceutical company primarily engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Intermediates, and Formulations. The company focuses on developing and producing a wide range of pharmaceutical products for various therapeutic segments. It operates modern manufacturing facilities and emphasizes research and development to maintain high-quality standards and meet regulatory requirements in the global pharmaceutical market.

Business Type:

Manufacturer (Factory)

Bajaj Healthcare Limited from India manufactures and sells a range of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. Their product portfolio includes APIs such as Hydroxyzine HCl, Levocetirizine Dihydrochloride, Cetirizine Dihydrochloride, Fexofenadine HCl, Mirtazapine, Escitalopram Oxalate, Sertraline HCl, Paroxetine HCl, Gliclazide, Glimepiride, Pioglitazone HCl, Fluconazole, Voriconazole, Olanzapine, Quetiapine Fumarate, Risperidone, Amlodipine Besylate, Telmisartan, Valsartan, Losartan Potassium, Sumatriptan Succinate, Zolmitriptan, Pantoprazole Sodium Sesquihydrate, Rabeprazole Sodium, Esomeprazole Magnesium Trihydrate, Doxylamine Succinate, Pregabalin, Gabapentin, Piracetam, and Roflumilast. They also engage in contract manufacturing of pharmaceutical formulations including tablets, capsules, and oral liquids.